Condition: HIV (Human Immunodeficiency Virus) · Continuum of Care · Stigma · Sponsor: University of California, Los Angeles
Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.
This description comes directly from the study's public registry record.
Chunqing Lin, PhD · 3107940361 · lincq@ucla.edu
Always discuss trial participation with your own doctor first.
| University of Medicine and Pharmacy | Ho Chi Minh City, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07495059